Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $5.91 Analyst target: $12.43 Upside: 110.32%
Orchestra BioMed Holdings, Inc. is a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. The company is headquartered in New Hope, Pennsylvania.
See the full interactive analysis & chart →Informational only — not investment advice.